Stratum-specific rate of sessile serrated polyps and clinically relevant serrated polyp
| Sessile serrated polyps | Clinically relevant serrated polyps | |||||
|---|---|---|---|---|---|---|
| 50–59 years | 60–69 years | ≥70 years | 50–59 years | 60–69 years | ≥70 years | |
| UK* | ||||||
| Male | – | – | – | – | 2.2 (2.1–2.3) | 2.1 (1.9–2.3) |
| Female | – | – | – | – | 1.9 (1.8–2.0) | 2.0 (1.8–2.2) |
| Spain* | ||||||
| Male | 4.1 (3.2–5.2) | 3.4 (2.6–4.4) | – | 6.4 (5.3–7.7) | 4.6 (3.7–5.7) | – |
| Female | 2.1 (1.4–3.0) | 2.8 (2.0–3.8) | – | 4.4 (3.4–5.7) | 4.1 (3.1–5.3) | – |
| Italy* | ||||||
| Male | – | 4.1 (3.7–4.6) | 3.2 (2.3–4.3) | – | 9.2 (8.6–9.8) | 8.3 (6.9–9.9) |
| Female | – | 2.4 (2.1–2.8) | 2.9 (2.0–4.1) | – | 6.2 (5.6–6.8) | 7.7 (6.1–9.5) |
| The Netherlands†‡ | ||||||
| Male | 5.5 (3.3–8.6) | 4.3 (2.5–6.8) | – | 4.0 (2.2–6.7) | 4.8 (2.9–7.4) | – |
| Female | 4.3 (2.4–7.0) | 5.2 (3.1–8.1) | – | 3.4 (1.8–5.9) | 5.7 (3.5–8.7) | – |
| Poland‡ | ||||||
| Male | 2.1 (1.6–2.7) | 2.0 (1.5–2.6) | – | – | – | – |
| Female | 2.0 (1.6–2.5) | 2.6 (2.1–3.2) | – | – | – | – |
*FOBT-based screening cohorts.
†Primary colonoscopy screening cohorts.
‡Forty-nine males and 69 females aged ≥70 were merged with participants 60–69 due to small sample size.
FOBT, faecal occult blood test.